{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:19:15Z","timestamp":1793272755410,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":3510,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1111\/jth.12176","type":"journal-article","created":{"date-parts":[[2013,2,18]],"date-time":"2013-02-18T11:05:03Z","timestamp":1361185503000},"page":"881-893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia"],"prefix":"10.1016","volume":"11","author":[{"given":"N.","family":"Narkbunnam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.-C.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.A.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.E.","family":"Monahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 77","key":"10.1111\/jth.12176_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/ort.1965.36.suppl-77.01","article-title":"Haemophilia in Sweden 7. Incidence treatment and prophylaxis of arthropathy and other musculo-skeletal manifestations of haemophilia A and B","author":"Ahlberg","year":"1965","journal-title":"Acta Orthop Scand"},{"key":"10.1111\/jth.12176_bb0015","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2516.2010.02472.x","article-title":"Pathophysiology, diagnosis and prevention of arthropathy in patients with haemophilia","volume":"17","author":"Dunn","year":"2011","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12176_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2008.01732.x","article-title":"Physiopathology of haemophilic arthropathy","volume":"14","author":"Lafeber","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12176_bb0025","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1302\/0301-620X.80B3.0800540","article-title":"Iron deposits and catabolic properties of synovial tissue from patients with haemophilia","volume":"80","author":"Roosendaal","year":"1998","journal-title":"J Bone Joint Surg Br"},{"key":"10.1111\/jth.12176_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2516.2006.01268.x","article-title":"Pathogenesis of haemophilic arthropathy","volume":"12","author":"Roosendaal","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12176_bb0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2141.2007.06490.x","article-title":"Modern management of haemophilic arthropathy","volume":"136","author":"Raffini","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12176_bb0040","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/1529-0131(199905)42:5<1033::AID-ANR24>3.0.CO;2-#","article-title":"Blood-induced joint damage: a canine in vivo study","volume":"42","author":"Roosendaal","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.12176_bb0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2559.1999.00608.x","article-title":"Haemophilic arthropathy resembles degenerative rather than inflammatory joint disease","volume":"34","author":"Roosendaal","year":"1999","journal-title":"Histopathology"},{"key":"10.1111\/jth.12176_bb0050","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2796.1997.130135000.x","article-title":"Haemophilia prophylaxis in young patients\u2013a long-term follow-up","volume":"241","author":"Lofqvist","year":"1997","journal-title":"J Intern Med"},{"key":"10.1111\/jth.12176_bb0055","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"357","author":"Manco-Johnson","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.12176_bb0060","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1651-2227.1981.tb05741.x","article-title":"Radiologic evaluation of prophylaxis in severe haemophilia","volume":"70","author":"Pettersson","year":"1981","journal-title":"Acta Paediatr Scand"},{"key":"10.1111\/jth.12176_bb0065","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/765624","article-title":"The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis","volume":"2011","author":"Hashizume","year":"2011","journal-title":"Arthritis"},{"key":"10.1111\/jth.12176_bb0070","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00296-010-1552-9","article-title":"IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis","volume":"31","author":"Yoshida","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1111\/jth.12176_bb0075","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/34.4.321","article-title":"Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor","volume":"34","author":"Mihara","year":"1995","journal-title":"Br J Rheumatol"},{"key":"10.1111\/jth.12176_bb0080","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/rheumatology\/ken363","article-title":"IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17","volume":"47","author":"Hashizume","year":"2008","journal-title":"Rheumatology"},{"key":"10.1111\/jth.12176_bb0085","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2011.08919.x","article-title":"Exploration of the pathogenesis of haemophilic joint arthropathy: understanding implications for optimal clinical management","volume":"156","author":"Acharya","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.12176_bb0090","first-page":"1132","article-title":"Anti-interleukin 6 receptor antibody inhibits murine AA-amyloidosis","volume":"31","author":"Mihara","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1111\/jth.12176_bb0095","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1002\/1529-0131(199812)41:12<2117::AID-ART6>3.0.CO;2-P","article-title":"Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis","volume":"41","author":"Takagi","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1111\/jth.12176_bb0100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.exer.2010.04.009","article-title":"Blockade of interleukin-6 signaling suppresses experimental autoimmune uveoretinitis by the inhibition of inflammatory Th17 responses","volume":"91","author":"Hohki","year":"2010","journal-title":"Exp Eye Res"},{"key":"10.1111\/jth.12176_bb0105","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.clinthera.2012.02.014","article-title":"Systematic review of tocilizumab for rheumatoid arthritis: a new biologic agent targeting the interleukin-6 receptor","volume":"34","author":"Navarro-Millan","year":"2012","journal-title":"Clin Ther"},{"key":"10.1111\/jth.12176_bb0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ng0595-119","article-title":"Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A","volume":"10","author":"Bi","year":"1995","journal-title":"Nat Genet"},{"key":"10.1111\/jth.12176_bb0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0165-2478(02)00202-X","article-title":"Characterization of anti-mouse interleukin-6 receptor antibody","volume":"84","author":"Okazaki","year":"2002","journal-title":"Immunol Lett"},{"key":"10.1111\/jth.12176_bb0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/B978-0-12-394596-9.00006-8","article-title":"Animal models of hemophilia","volume":"105","author":"Sabatino","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1111\/jth.12176_bb0125","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2516.2008.01689.x","article-title":"Experimental haemophilic arthropathy in a mouse model of a massive haemarthrosis: gross, radiological and histological changes","volume":"14","author":"Hakobyan","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12176_bb0130","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/j.1538-7836.2008.02954.x","article-title":"Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice","volume":"6","author":"Ovlisen","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12176_bb0135","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2008-01-131417","article-title":"Intraarticular factor IX protein or gene replacement protects against development of hemophilic synovitis in the absence of circulating factor IX","volume":"112","author":"Sun","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.12176_bb0140","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2516.2011.02608.x","article-title":"Pharmacokinetics and pharmacodynamics of a new recombinant FVIII (N8) in haemophilia A mice","volume":"18","author":"Elm","year":"2012","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12176_bb0145","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-2516.2006.01348.x","article-title":"Histological changes in murine haemophilic synovitis: a quantitative grading system to assess blood-induced synovitis","volume":"12","author":"Valentino","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12176_bb0150","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2106\/00004623-197153030-00009","article-title":"Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data","volume":"53","author":"Mankin","year":"1971","journal-title":"J Bone Joint Surg Am"},{"key":"10.1111\/jth.12176_bb0155","doi-asserted-by":"crossref","first-page":"R492","DOI":"10.1186\/ar1219","article-title":"Acoustic stiffness and change in plug cartilage over time after autologous osteochondral grafting: correlation between ultrasound signal intensity and histological score in a rabbit model","volume":"6","author":"Kuroki","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/jth.12176_bb0160","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2006-05-020495","article-title":"Cutaneous wound healing is impaired in hemophilia B","volume":"108","author":"Hoffman","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.12176_bb0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1182\/blood-2008-04-151597","article-title":"Anti-CD3 prevents factor VIII inhibitor development in hemophilia A mice by a regulatory CD4+CD25+-dependent mechanism and by shifting cytokine production to favor a Th1 response","volume":"113","author":"Waters","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.12176_bb0170","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.intimp.2008.07.002","article-title":"Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production","volume":"8","author":"Uchiyama","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1111\/jth.12176_bb0175","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.autrev.2009.01.012","article-title":"Interleukin-6 as a key player in systemic inflammation and joint destruction","volume":"8","author":"Fonseca","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1111\/jth.12176_bb0180","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1002\/eji.201040391","article-title":"IL-6: regulator of Treg\/Th17 balance","volume":"40","author":"Kimura","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1111\/jth.12176_bb0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3109\/s10165-010-0325-3","volume":"21","author":"Hashimoto","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1111\/jth.12176_bb0190","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","article-title":"Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial","volume":"371","author":"Yokota","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/jth.12176_bb0195","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2008.092866","article-title":"Long-term safety and efficacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and efficacy in a 5-year extension study","volume":"68","author":"Nishimoto","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/jth.12176_bb0200","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","article-title":"Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis","volume":"367","author":"De Benedetti","year":"2012","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1111\/jth.12176_bb0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/jth.12101","article-title":"Nuclear Factor (NF)-kappaB and its associated pathways are major molecular regulators of blood induced joint damage in a murine model of hemophilia","volume":"11","author":"Sen","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"Suppl 2","key":"10.1111\/jth.12176_bb0210","first-page":"225","article-title":"TNF-alpha antagonists augment factor replacement to prevent arthropathy in hemophilic mice","volume":"7","author":"Sun","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12176_bb0215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ajh.2830500202","article-title":"Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation","volume":"50","author":"Chang","year":"1995","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.12176_bb0220","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/j.1538-7836.2010.03962.x","article-title":"Blood-induced joint disease: the pathophysiology of hemophilic arthropathy","volume":"8","author":"Valentino","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.12176_bb0225","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1365-2516.2008.01973.x","article-title":"IL-1 beta, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis","volume":"15","author":"Ovlisen","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12176_bb0230","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1365-2516.2012.02835.x","article-title":"Consequences of intra-articular bleeding in haemophilia: science to clinical practice and beyond","volume":"18","author":"Forsyth","year":"2012","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12176_bb0235","first-page":"116","article-title":"Association of hemophilic arthropathy with genetic markers related to bleeding tendency, joint inflammation and structural cartilage","volume":"18","author":"Lopez-Jimenez","year":"2012","journal-title":"Haemophilia"},{"key":"10.1111\/jth.12176_bb0240","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1538-7836.2009.03636.x","article-title":"Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A","volume":"7","author":"Pavlova","year":"2009","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12176","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.12176","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622136135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622136135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.12176\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:07:35Z","timestamp":1761534455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622136135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1538783622136135"],"URL":"https:\/\/doi.org\/10.1111\/jth.12176","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-6 receptor antagonist as adjunctive therapy with clotting factor replacement to protect against bleeding-induced arthropathy in hemophilia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.12176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}